A61K 38/25
Growth hormone-releasing factor [gh-rf], i.e. somatoliberin
Official title: Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
A61K38/25 (Growth hormone-releasing factor [gh-rf], i.e. somatoliberin) appears on 228 US grants and 282 published applications in this corpus.
Search patents in A61K- Granted patents
- 228
- Published applications
- 282
- Assignees
- 164
- Inventors
- 504
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 6 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 10 | 0 |
| 1996 | 3 | 0 |
| 1997 | 12 | 0 |
| 1998 | 8 | 0 |
| 1999 | 6 | 0 |
| 2000 | 6 | 0 |
| 2001 | 5 | 3 |
| 2002 | 7 | 10 |
| 2003 | 4 | 12 |
| 2004 | 3 | 11 |
| 2005 | 6 | 12 |
| 2006 | 3 | 15 |
| 2007 | 5 | 12 |
| 2008 | 3 | 11 |
| 2009 | 2 | 16 |
| 2010 | 10 | 23 |
| 2011 | 7 | 15 |
| 2012 | 11 | 8 |
| 2013 | 10 | 12 |
| 2014 | 14 | 15 |
| 2015 | 8 | 10 |
| 2016 | 15 | 10 |
| 2017 | 6 | 18 |
| 2018 | 5 | 7 |
| 2019 | 7 | 6 |
| 2020 | 5 | 11 |
| 2021 | 8 | 11 |
| 2022 | 4 | 5 |
| 2023 | 3 | 16 |
| 2024 | 2 | 5 |
| 2025 | 6 | 4 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of prostate cancer with a combination of abiraterone acetate, niraparib tosylate monohydrate and prednisone15 Sep 2026US 12,734,180 B2Janssen Pharmaceutica NV
- Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof7 Oct 2025US 12,433,935 B2Samsung Life Public Welfare Foundation
- GHRH antagonists for use in a method of treating sarcoidosis5 Aug 2025US 12,377,135 B2The United States Government as represented by the Department of Veterans Affairs
- Des-acyl ghrelin and analogs as cancer therapies27 May 2025US 12,311,011 B2Cornell University
- GHRH or analogues thereof for use in treatment of hepatic disease25 Feb 2025US 12,233,107 B2The General Hospital Corporation
- Injectable nutrient solution30 Apr 2026US 2026/0115244 A1
- Treatment of prostate cancer with a combination of abiraterone acetate and niraparib9 Apr 2026US 2026/0097048 A1Janssen Pharmaceutica NV
- Treatment of mild traumatic brain injury19 Mar 2026US 2026/0077018 A1Oxeia Biopharmaceuticals, Inc.
- Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof5 Mar 2026US 2026/0061034 A1Samsung Life Public Welfare Foundation
- Ghrh antagonists for use in a method of treating sarcoidosis30 Oct 2025US 2025/0332223 A1The United States Government as represented by the Department of Veterans Affairs
Most cited
By later US patents
- Oral drug delivery compositions and methods186US 5,792,451 AEmisphere Technologies, Inc. · 1998
- Compounds and compositions for delivering active agents184US 5,643,957 AEmisphere Technologies, Inc. · 1997
- Modified amino acids for encapsulating active agents154US 5,451,410 AEmisphere Technologies, Inc. · 1995
- Convertible microemulsion formulations135US 5,444,041 AIbah, Inc. · 1995
- Oral drug delivery compositions and methods133US 5,766,633 AEmisphere Technologies, Inc. · 1998